glp-1 bone density loss and GIP: Magic bullet for musculoskeletal diseases? GLP-1 medications can support weight

Understanding how and when to use GLP1s in the context of liver disease can offer clinicians a more nuanced approach that aligns treatment with underlying metabolic dysfunction rather than surface phenotypes

Total body fat percentage slightly decreased (from 65% to 63.7%), and significant improvements were noted in insulin resistance, liver transaminase levels, and lipid profiles

In terms of nutritional differences, grass-fed beef naturally contains lower levels of total fat and saturated fat compared to grain-fed beef

GLP-1 receptor agonist drugs (Ozempic, Victoza, etc.) mimic this natural hormone at its receptor, lasting hours to days instead of 12 minutes

Excess body fat, particularly visceral fat, converts testosterone to estrogen through a process called aromatization

Angel Roque, culinary director, collaborated with Philadelphia-area internist and weight-loss specialist Dr